Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
SHIB Japan Milestone Meets Key Price Resistance

SHIB Japan Milestone Meets Key Price Resistance

CryptonewslandCryptonewsland2026/08/25 18:45
By:Cryptonewsland
  • SHIB Japan milestone adds regulated market access, while price recovery faces resistance near $0.00000555 after heavy intraday selling.
  • SHIB rebounds from $0.00000525 as buyers return, while declining volume leaves the recovery facing a key resistance test.
  • Japan’s regulated market adds another SHIB development as price holds above $0.00000540 following a sharp daily decline.


SHIB Japan milestone adds regulated market access, while the token recovers from a sharp decline and approaches resistance near the upper daily range.

Japan Registration Opens Another Market Route

Shib announced the SHIB Japan milestone through its latest social media update. The post said SHIB joined six assets supported by Laser Digital Japan. It followed the company’s completion of regulatory registration in Japan.

The initial asset group includes Bitcoin, Ethereum, XRP, Bitcoin Cash, Litecoin, and SHIB. Laser Digital Japan completed its registration on August 21. The registration followed four years without another new exchange-provider approval.

Laser Digital Japan is backed by Nomura and will initially provide liquidity. Its stated focus includes domestic virtual-asset service providers. The company also plans services targeting institutional digital-asset trading.

Japan’s regulatory framework is also moving toward broader oversight. Recent reforms are likely to contribute to enhanced supervision of crypto assets. This will be in effect from 2027 onwards. .

Price Recovers After a Sharp Intraday Drop

SHIB is trading around $0.000005519 as of writing. The token has risen around 0.59% in the past 24 hours. Towards the end of the session, however, the price had a sudden drop to the $0.00000525 level.

Trading initially centered around 0.00000550-0.00000552. Prices were bid up to approximately $0.00000542, with sellers taking over the bids. Buyers reacted and then rallied the token back up from below $0.00000550.

Selling pressure later intensified, sending the price toward approximately $0.00000525. Several recovery attempts initially failed near the session lows. Price eventually established higher lows and began recovering steadily.

The rebound then carried SHIB through $0.00000530 and $0.00000540. Price subsequently rallied back up to about $0.00000552. This recovery places the $0.00000552 to $0.00000555 zone directly ahead.

Volume Declines as Resistance Remains Nearby

 Price is as of writing supported on the $0.00000540 level, which is near the base of the formation. Below that area, demand appears around $0.00000525 to $0.00000530. A move below this range would weaken the latest recovery structure.

Meanwhile, SHIB’s market capitalization stands near $3.25 billion. Its reported 24-hour volume is approximately $122.2 million. Trading volume has declined by 66.82% during the measured period.

The chart lists approximately 589.23 trillion SHIB in circulation. Maximum supply stands near 589.55 trillion SHIB. The platform also records roughly 3.07 million holders.

The Japanese development adds regulated-market infrastructure to SHIB’s broader expansion. Price action, however, remains focused on nearby technical levels. A break above $0.00000555 would challenge the current range, while rejection would retain the existing resistance structure.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

"Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?

The Nasdaq 100 Index fell by 6.4%, wiping out $2.3 trillion in market capitalization. The core reason behind this decline is concerns that a comprehensive victory by the Democratic Party could lead to stricter regulations on AI development. Systematic funds, which typically follow the stock market's trend and respond to price fluctuations and momentum signals, were thus forced to reduce their investments, accelerating the downturn. The selling pressure from systematic strategies may not be over yet; it is expected that in the coming days, portfolios targeting volatility will sell at least $50 billion worth of stocks.

智通财经•2026/11/06 12:19

The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives

For months, investors have been worried about a series of risks behind the AI (artificial intelligence) capital expenditure "money tree." This week, the market finally pressed the panic selling button.

智通财经•2026/11/06 11:26
The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives